A Review on Role of Laser Photocoagulation Therapy in Diabetic Retinopathy

  • Posted on: 1 February 2015
  • By: admin

 

Magazine Home


FEB 2015 ARTICLE LIST >>

PharmaTutor (February- 2015)

 

Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 2)

 

Received On: 22/11/2014; Accepted On: 26/11/2014; Published On: 01/02/2015

 

AUTHORS: M. Sushma*, T. V. V. Vidyadhar, M. Babu M.D., R. Mohan raj
*Department of Pharmacy Practice,
Raghavendra Institute of Pharmaceutical Education & Research, RIPER.
K R Palli Cross, Near S.K University, Anantapuramu District, Andhra Pradesh
sushma.banthi@gmail.com

 

ABSTRACT: Diabetic retinopathy, one of the leading causes of blindness for diabetic patients between the ages of 20 and 74. The clinical research provides control of blood glucose and blood pressure substantially reduces the risk of blindness due to diabetic retinopathy, many patients develop this eye disease and are at risk for serious vision loss, sometimes even despite outstanding metabolic control. Diabetic retinopathy occurs when high blood glucose damages the micro blood vessels in the retina which leads to leakage of small amounts of blood, serum, blood fats and blood proteins proliferates to vision loss and formation of scar tissue. Here the retinal laser therapy also called aslaser photocoagulation has greatly reduced the number of patients who lose vision to Diabetic retinopathy. Laser photocoagulation refers to the precise and concentrated application of high energy light, typically of a single wavelength called monochromatic light.

<

 

How to cite this article: M Sushma, TVV Vidyadhar, M Babu, R Mohanraj; A Review on Role of Laser Photocoagulation Therapy in Diabetic Retinopathy; PharmaTutor; 2015; 3(2); 8-18

 

[ABSTRACT WITH CITATION]   [VIEW AS HTML]